| 688137 Stock | | | 32.48 0.59 1.78% |
Suzhou Novoprotein financial indicator trend analysis is much more than just breaking down Suzhou Novoprotein prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Suzhou Novoprotein is a good investment. Please check the relationship between Suzhou Novoprotein Operating Income and its Reconciled Depreciation accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Operating Income vs Reconciled Depreciation
Operating Income vs Reconciled Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Suzhou Novoprotein Operating Income account and
Reconciled Depreciation. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Suzhou Novoprotein's Operating Income and Reconciled Depreciation is -0.63. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Suzhou Novoprotein Scientific, assuming nothing else is changed. The correlation between historical values of Suzhou Novoprotein's Operating Income and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Suzhou Novoprotein Scientific are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Operating Income i.e., Suzhou Novoprotein's Operating Income and Reconciled Depreciation go up and down completely randomly.
Correlation Coefficient | -0.63 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Operating Income
Operating Income is the amount of profit realized from Suzhou Novoprotein operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Suzhou Novoprotein Scientific is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Reconciled Depreciation
Most indicators from Suzhou Novoprotein's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Suzhou Novoprotein current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The current year's
Tax Provision is expected to grow to about (5.7
M). In addition to that,
Selling General Administrative is expected to decline to about 55.3
MSuzhou Novoprotein fundamental ratios Correlations
Click cells to compare fundamentals
Suzhou Novoprotein Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Suzhou Stock
Balance Sheet is a snapshot of the
financial position of Suzhou Novoprotein at a specified time, usually calculated after every quarter, six months, or one year. Suzhou Novoprotein Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Suzhou Novoprotein and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Suzhou currently owns. An asset can also be divided into two categories, current and non-current.